Dana-Farber Brigham Cancer Center is ranked best in New England

For the 21st straight year, Dana-Farber Brigham Cancer Center has been recognized as a Best Hospital for cancer care by U.S. News & World Report. Dana-Farber Brigham Cancer Center is ranked as the best hospital for cancer care in New England and #4 in the nation this year (2021-22).

The annual U.S. News Best Hospitals ratings are designed to assist patients and their doctors in making informed decisions about where to receive care for challenging health conditions or for common elective procedures.

“We are immensely proud of this recognition as it is testament to the skill and commitment of everyone at Dana-Farber Brigham Cancer Center. We continuously strive to provide the highest quality and most compassionate care to our patients and families. In our unwavering pursuit of excellence, we also search relentlessly to find new cures and treatments for patients with cancer around the world,” said Laurie H. Glimcher, MD, president and CEO, Dana-Farber Cancer Institute.

“Dana-Farber Brigham Cancer Center has been consistently ranked as one of the top hospitals to receive cancer care over the past two decades. This longstanding acknowledgement recognizes the commitment of our multidisciplinary teams that collaborate to provide compassionate, world-class and personalized cancer care to our patients and their loved ones and pursue breakthroughs that give hope to people facing cancer here in New England and around the world,” said Sunil Eappen, MD, MBA, interim president, Brigham and Women’s Hospital.

Dana-Farber Brigham Cancer Center brings together specialists from two world-class medical centers. With deep experience in treating various cancers and including experts from a wide span of disciplines, such as medical and radiation oncologists, cancer surgeons and many others, patients have access to the latest treatments along with clinical trials for promising new therapies.

/Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.